Actos News Shows Increase in Actos Bladder Cancer Lawsuits
The latest Actos news points to a rise in Actos bladder cancer lawsuits, which began with the first lawsuit filed in August, 2011. Following the FDA warning about Actos bladder cancer in June, awareness of the link between the diabetes drug and bladder cancer spread nationwide. Many patients who have had their bladders removed as part of their cancer treatment are now coming forward to file an Actos bladder cancer lawsuit.
Actos Cancer News Came to a Head in June
Studies have indicated a possible link between Actos and bladder cancer for several years now, but it wasn’t until September of 2010 that the FDA announced they were seriously looking into the issue. They then reviewed the preliminary results from a 10-year post-marketing study conducted by Actos manufacturer Takeda, and discovered that those patients taking high doses of Actos, or those taking Actos for more than a year, had a 40 percent increased risk of Actos bladder cancer.
The FDA announced its findings in June of 2011, after which Actos cancer news spread like wildfire. Only a few days before, the French Medicines Agency announced a new Actos recall, following the release of data from a French epidemiological study that also indicated a link between Actos and bladder cancer. Soon after, Germany advised physicians not to recommend the drug to any other patients.
Actos News Now Involves Lawsuits
Since the first Actos bladder cancer lawsuit was filed in August, several more have followed suit. Actos bladder cancer news has reported on patients who were diagnosed in 2008 or 2009, for example, who only now are realizing the connection to their diabetes drug because of the FDA announcement. Many have had to have part or all of their bladders removed, and some continue to experience side effects of the disease.
Actos bladder cancer news has also featured spouses of the victims, who may be affected by these serious injuries. Spouses may experience loss of consortium and emotional support as well as loss of income because the injured spouse is no longer able to work, or lost a lot of time at work.
Actos Bladder Cancer News Resulted in Class Action Suit
A new Actos bladder cancer class action lawsuit was recently filed in Louisiana, with the Actos lawyer alleging that the drug is responsible for the plaintiffs’ bladder cancer, and that Takeda failed to adequately warn of the risks. Patients who took the drug at any time since its approval in 1999 may be eligible to join.
Meanwhile, in Actos cancer news, the number of individual lawsuits continues to increase, enough that the U.S. Judicial Panel on Multidistrict Litigation may approve consolidation of all cases into one court. The panel is expected to meet on the issue in December 2011.
An Actos Bladder Cancer Lawyer May be Able to Help
If you or a loved one has suffered from Actos bladder cancer, you may be eligible for compensation in a bladder cancer lawsuit. Contact Chaffin Luhana LLP today for a confidential case evaluation at 1-888-480-1123.